Oxford Asset Management’s Vanda Pharmaceuticals VNDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q1
Sell
-129,045
Closed -$2.12M 1279
2019
Q4
$2.12M Buy
129,045
+36,850
+40% +$605K 0.06% 390
2019
Q3
$1.22M Buy
92,195
+66,489
+259% +$883K 0.03% 822
2019
Q2
$362K Buy
+25,706
New +$362K 0.01% 1395
2019
Q1
Sell
-55,298
Closed -$1.45M 2001
2018
Q4
$1.45M Sell
55,298
-55,064
-50% -$1.44M 0.04% 663
2018
Q3
$2.52M Buy
110,362
+1,622
+1% +$37K 0.05% 533
2018
Q2
$2.07M Sell
108,740
-11,684
-10% -$222K 0.04% 646
2018
Q1
$2.03M Buy
120,424
+96,909
+412% +$1.63M 0.04% 565
2017
Q4
$358K Sell
23,515
-152,650
-87% -$2.32M 0.01% 1291
2017
Q3
$3.18M Sell
176,165
-48,116
-21% -$869K 0.06% 380
2017
Q2
$3.66M Buy
224,281
+24,679
+12% +$402K 0.07% 295
2017
Q1
$2.79M Sell
199,602
-557,905
-74% -$7.81M 0.07% 309
2016
Q4
$12.1M Sell
757,507
-247,823
-25% -$3.95M 0.43% 35
2016
Q3
$16.7M Buy
+1,005,330
New +$16.7M 0.52% 34
2016
Q2
Sell
-69,999
Closed -$585K 884
2016
Q1
$585K Buy
+69,999
New +$585K 0.02% 589
2015
Q4
Sell
-157,841
Closed -$1.78M 952
2015
Q3
$1.78M Buy
+157,841
New +$1.78M 0.06% 306
2015
Q2
Sell
-86,041
Closed -$800K 746
2015
Q1
$800K Sell
86,041
-254,246
-75% -$2.36M 0.02% 493
2014
Q4
$4.95M Buy
340,287
+292,681
+615% +$4.26M 0.11% 204
2014
Q3
$500K Buy
+47,606
New +$500K 0.01% 551
2014
Q2
Sell
-180,017
Closed -$2.93M 783
2014
Q1
$2.93M Buy
+180,017
New +$2.93M 0.09% 296
2013
Q4
Sell
-220,537
Closed -$2.42M 792
2013
Q3
$2.42M Buy
+220,537
New +$2.42M 0.05% 404